Presentation Developed by Allergan Aesthetics, HArmonyCa stands out as a next-generation hybrid dermal filler. This innovative medical device merges the benefits of two leading aesthetic molecules to address the complex needs of aging skin. It helps restore lost volume while sustainably improving the structural quality of the skin, marking a major advancement in the injectables market.
Composition
& Rheology Cross-linked Hyaluronic Acid (HA): provides immediate volume and allows for precise contouring. Calcium Hydroxyapatite (CaHA) microspheres: act as a deep biorevitalizer to restart fibroblastic production.
Indications
This treatment is recommended for correcting facial ptosis and augmenting sagging soft tissues. It specifically targets areas requiring deep facial restructuring, offering a comprehensive solution for individuals showing moderate to severe signs of aging and loss of skin density.
Posology Administration is performed via injection into the deep dermis or hypodermis (sub-dermal layers). The highly malleable gel must be evenly distributed by a qualified practitioner to optimize volume repositioning and cellular stimulation. Storage Store in a dry place, away from direct sunlight, at a controlled room temperature.
Do not freeze and keep in its original packaging until use. Contraindications Known hypersensitivity to hyaluronic acid or CaHA particles. Presence of active infections or inflammation in the treatment area. Pregnant or breastfeeding women. Patients prone to hypertrophic scarring or keloids.
FAQ
What are the benefits of a hybrid filler? The synergy between HA and CaHA provides a visible volumizing result immediately after the session, while ensuring a progressive improvement in skin firmness thanks to neocollagenesis that begins within the first week. How long do the effects last?
The combined action offers prolonged longevity compared to a standard filler, as the newly formed collagen matrix naturally supports the tissues over the long term.
